NCT07098858 The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)
| NCT ID | NCT07098858 |
| Status | Recruiting |
| Phase | — |
| Sponsor | EBR Systems, Inc. |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 320 participants |
| Start Date | 2025-11-03 |
| Primary Completion | 2032-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 320 participants in total. It began in 2025-11-03 with a primary completion date of 2032-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observe to understand product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System
Eligibility Criteria
* Patient or legally authorized representative can provide written authorization and/or consent per institution requirements. * Patient is intended to receive a WiSE System and passed the acoustic window screening * Patient who is, or will be, accessible for follow-up. * Participation is not excluded by local law. * Patient is not enrolled in a concurrent drug and/or device study that may confound the Registry results. * Patient life expectancy \>1 year.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07098858 clinical trial?
This trial is open to participants of all sexes, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07098858 currently recruiting?
Yes, NCT07098858 is actively recruiting participants. Contact the research team at clinical@ebrwise.com for enrollment information.
Where is the NCT07098858 trial being conducted?
This trial is being conducted at Jonesboro, United States, Naples, United States, Ann Arbor, United States, New York, United States and 1 additional location.
Who is sponsoring the NCT07098858 clinical trial?
NCT07098858 is sponsored by EBR Systems, Inc.. The trial plans to enroll 320 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.